全文获取类型
收费全文 | 91291篇 |
免费 | 5631篇 |
国内免费 | 638篇 |
专业分类
林业 | 4863篇 |
农学 | 2677篇 |
基础科学 | 702篇 |
11523篇 | |
综合类 | 16987篇 |
农作物 | 3290篇 |
水产渔业 | 4137篇 |
畜牧兽医 | 46534篇 |
园艺 | 1343篇 |
植物保护 | 5504篇 |
出版年
2021年 | 819篇 |
2020年 | 938篇 |
2019年 | 1035篇 |
2018年 | 1607篇 |
2017年 | 1816篇 |
2016年 | 1616篇 |
2015年 | 1523篇 |
2014年 | 1710篇 |
2013年 | 3434篇 |
2012年 | 3334篇 |
2011年 | 3940篇 |
2010年 | 2571篇 |
2009年 | 2397篇 |
2008年 | 3502篇 |
2007年 | 3411篇 |
2006年 | 3077篇 |
2005年 | 2954篇 |
2004年 | 2651篇 |
2003年 | 2687篇 |
2002年 | 2519篇 |
2001年 | 2676篇 |
2000年 | 2722篇 |
1999年 | 2079篇 |
1998年 | 850篇 |
1997年 | 748篇 |
1995年 | 821篇 |
1993年 | 710篇 |
1992年 | 1614篇 |
1991年 | 1810篇 |
1990年 | 1766篇 |
1989年 | 1725篇 |
1988年 | 1584篇 |
1987年 | 1621篇 |
1986年 | 1667篇 |
1985年 | 1492篇 |
1984年 | 1277篇 |
1983年 | 1096篇 |
1982年 | 728篇 |
1979年 | 1155篇 |
1978年 | 903篇 |
1977年 | 739篇 |
1976年 | 769篇 |
1975年 | 808篇 |
1974年 | 1071篇 |
1973年 | 1078篇 |
1972年 | 1014篇 |
1971年 | 947篇 |
1970年 | 930篇 |
1969年 | 880篇 |
1967年 | 760篇 |
排序方式: 共有10000条查询结果,搜索用时 203 毫秒
991.
Network on veterinary medicines initiated by the European Federation For Pharmaceutical Sciences 下载免费PDF全文
L. Dencker R. T. Cristina H. Linden I. Schmerold 《Journal of veterinary pharmacology and therapeutics》2018,41(3):378-383
The European Federation for Pharmaceutical Sciences (EUFEPS) was founded 25 years ago by more than 20 national pharmaceutical societies and faculty members. As a pan‐European organization, it brings together pharmaceutical societies as well as academic, industrial and regulatory scientists engaged in drug research and development, drug regulation and education of professionals working in these fields. EUFEPS represents pharmaceutical sciences in Europe and is recognized as such by both the European Commission and the European Medicines Agency. EUFEPS cooperates with the European Federation of Pharmaceutical Industries and other European organizations and maintains global connections with agencies such as the US Food and Drug Administration and the American Association of Pharmaceutical Scientists. EUFEPS has established specified networks forming the basis of its activities. The creation of a Network on Veterinary Medicines is prompted by the manifold problems resulting from the use of veterinary drugs and its inherent interconnections with human medicine, environmental and public health. A long‐term goal of this initiative was to expand the spectrum of available therapeutics for use in animals, including the development of innovative delivery systems. 相似文献
992.
O. L. Levionnois T. K. Fosse B. Ranheim 《Journal of veterinary pharmacology and therapeutics》2018,41(2):314-323
Flunixin is marketed in several countries for analgesia in adult swine but little is known about its efficacy in piglets. Thirty‐two piglets (6–8 days old) were randomized to receive placebo saline (n = 11, group CONTROL) or flunixin meglumine intravenously at 2.2 (n = 11, group MEDIUM) or 4.4 (n = 10, group HIGH) mg/kg, 10 hr after subcutaneous injection of kaolin in the left metacarpal area. A hand‐held algometer was used to determine each piglet’s mechanical nociceptive threshold (MNT) from both front feet up to 50 hr after treatment (cut‐off value of 24.5 newton). Serial venous blood samples were obtained to quantify flunixin in plasma using LC‐MS/MS. A PKPD model describing the effect of flunixin on the mechanical nociceptive threshold was obtained based on an inhibitory indirect response model. A two‐compartmental PK model was used. A significant effect of flunixin was observed for both doses compared to control group, with 4.4 mg/kg showing the most relevant (6–10 newton) and long‐lasting effect (34 hr). The median IC50 was 6.78 and 2.63 mg/ml in groups MEDIUM and HIGH, respectively. The ED50 in this model was 6.6 mg/kg. Flunixin exhibited marked antinociceptive effect on kaolin‐induced inflammatory hyperalgesia in piglets. 相似文献
993.
994.
In vitro evaluation of a simulated pneumoperitoneum environment using carbon dioxide on canine transitional cell carcinoma 下载免费PDF全文
995.
Pharmacokinetics of multiple doses of transdermal flunixin meglumine in adult Holstein dairy cows 下载免费PDF全文
M. D. Kleinhenz P. J. Gorden J. S. Smith J. A. Schleining K. E. Kleinhenz L. L. Wulf P. K. Sidhu D. Rea J. F. Coetzee 《Journal of veterinary pharmacology and therapeutics》2018,41(3):490-493
A transdermal formulation of the nonsteroidal anti‐inflammatory drug, flunixin meglumine, has been approved in the United States and Canada for single‐dose administration. Transdermal flunixin meglumine was administered to 10 adult Holstein cows in their second or third lactation at the label dose of 3.33 mg/kg every 24 hr for three total treatments. Plasma flunixin concentrations were determined using high‐pressure liquid chromatography with mass spectroscopy (HPLC ‐MS ). Pharmacokinetic analysis was completed on each individual animal with noncompartmental methods using computer software. The time to maximum drug concentration (T max) was 2.81 hr, and the maximum drug concentration was 1.08 μg/ml. The mean terminal half‐life (T½) was determined to be 5.20 hr. Clearance per fraction absorbed (Cl/F) was calculated to be 0.294 L/hr kg?1, and volume of distribution of fraction (V z/F ) absorbed was 2.20 L/kg. The mean accumulation factor was 1.10 after three doses. This indicates changes in dosing may not be required when giving multiple doses of flunixin transdermal. Further work is required to investigate the clinical efficacy of transdermal flunixin after multiple daily doses. 相似文献
996.
M. G. Wagener S. Leonhard‐Marek J.‐D. Häger C. Pfarrer 《Anatomia, histologia, embryologia》2018,47(3):268-270
Mastitis is a common economically relevant problem in dairy farming. As the major entry for pathogens is the papillary duct, one of the first defence mechanisms is the teat sphincter. This sphincter shows a rhythmic contractility of yet unknown origin. Searching for possible modulatory pacemaker cells, teat sphincters of eight cows were stained immunohistochemically with antibodies against CD117 and vimentin and evaluated microscopically for the presence of telocytes. CD117‐ and vimentin‐positive telocytes with telopodes were found in close contact with smooth muscle cells. Our findings present a first evidence of telocytes in the teat of bovines. 相似文献
997.
998.
999.
1000.
The effect of maternal obesity on fatty acid transporter expression and lipid metabolism in the full‐term placenta of lean breed swine 下载免费PDF全文
L. Tian S. S. Dong J. Hu J. J. Yao P. S. Yan 《Journal of animal physiology and animal nutrition》2018,102(1):e242-e253
This study was conducted to evaluate the influence of back‐fat thickness (BF), at mating of sows, on the maternal and newborn circulating lipids, expression of placental fatty acids (FA) transporters and lipid accumulation in placenta. Full‐term placentas were obtained by vaginal delivery from BFI (9–14 mm; n = 37), BFII (15–19 mm; n = 43) and BFIII (20–27 mm; n = 38) sows according to BF at mating, and frozen placental sections were analysed for fat accumulation. Blood samples were collected from the sows of day 105 pregnancy and from cord blood at delivery. mRNA and protein expression levels were evaluated with real‐time RT‐PCR and Western blotting. Our results demonstrated that BFII females had significantly increased litter weight and placental efficiency, decreased maternal triglyceride (TG) and non‐esterified fatty acids (NEFA) levels, decreased maternal IL‐6, TNFα and leptin levels compared to BFIII females (p < .05). BFIII sows were associated with significantly decreased newborn TG levels, increased newborn glucose, IL‐6 and TNFα levels compared to BFI or BFII sows (p < .05). BFI and BFII females had significantly decreased placental TG, NEFA and cholesterol (CHOL) contents compared to BFIII females (p < .05). Moreover, decreased CD36, FATP1, FABP4, and FABP1 mRNA and protein and FATP4 protein expression, and increased LPL activity were also observed in BFIII group compared with BFII group (p < .05). PPARγ mRNA and protein and lipogenic genes such as SREBP‐1c, ACSL1, ACCα, FAS and SCD mRNA expression were downregulated or upregulated, respectively, in the placentas of BFIII sows compared to BFI or BFII sows (p < .05). Overall, this study demonstrated that there is no advantage, in terms of litter live size, litter weight and placental FA transport and metabolism, in performing the mating of sows with BF>19 mm. 相似文献